Suppr超能文献

黏液样胞外多糖(藻酸盐)在抗生素诱导及多形核白细胞介导的铜绿假单胞菌杀伤中的功能作用

Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa.

作者信息

Bayer A S, Speert D P, Park S, Tu J, Witt M, Nast C C, Norman D C

机构信息

Department of Medicine, Harbor-UCLA Medical Center, Torrance 90509.

出版信息

Infect Immun. 1991 Jan;59(1):302-8. doi: 10.1128/iai.59.1.302-308.1991.

Abstract

We evaluated in vitro the functional role of mucoid exopolysaccharide (MEP) of Pseudomonas aeruginosa in blocking antibiotic-induced and polymorphonuclear leukocyte (PMN)-mediated pseudomonal killing. The serum-resistant P. aeruginosa isolates used were mucoid strain 144MR and its nonmucoid revertant, strain 144NM. By timed kill curves, early bacterial effects of amikacin against mucoid strain 144MR were substantially less than those observed with nonmucoid strain 144NM; this effect was reversible with enzymatic hydrolysis of MEP of strain 144MR by alginase. Also, early tobramycin uptake (15 to 30 min) by mucoid 144MR cells was less than that seen with nonmucoid strain 144NM; pretreatment of 144MR cells with alginase substantially enhanced early tobramycin uptake compared with untreated 144MR cells (P = 0.08). In strain 144NM (but not in strain 114MR) there was a notable postantibiotic leukocidal enhancement effect manifested by increased nonopsonic killing following brief exposure of these cells to supra-MIC amikacin; pretreatment of strain 144MR with alginase rendered these cells more susceptible to amikacin-induced postantibiotic leukocidal enhancement. Similarly, direct PMN-mediated nonopsonic killing of mucoid strain 144MR was significantly less than that observed with strain 144NM (P less than 0.05); pretreatment of 144MR cells with alginase rendered this strain equal to strain 144NM in susceptibility to nonopsonic killing. In addition, exogenous sodium alginate or extracted MEP of strain 144MR interfered with effective nonopsonic killing of strain 144NM by PMNs. Studies also indicated that mucoid strain 144MR was phagocytosed significantly less well than its nonmucoid mate (P less than 0.00001), an effect reversed by pretreatment of the mucoid cells with alginase. These data confirm that P. aeruginosa MEPs functionally decrease the uptake and early bactericidal effect of aminoglycosides in vitro and interfere with effective PMN-mediated nonopsonic phagocytosis and killing of mucoid strains.

摘要

我们在体外评估了铜绿假单胞菌的黏液样胞外多糖(MEP)在阻断抗生素诱导及多形核白细胞(PMN)介导的假单胞菌杀伤中的功能作用。所使用的血清耐受型铜绿假单胞菌分离株为黏液样菌株144MR及其非黏液样回复株144NM。通过定时杀菌曲线可知,阿米卡星对黏液样菌株144MR的早期细菌效应显著低于非黏液样菌株144NM;用藻酸酶对144MR菌株的MEP进行酶解后,这种效应是可逆的。此外,黏液样144MR细胞对妥布霉素的早期摄取(15至30分钟)低于非黏液样菌株144NM;与未处理的144MR细胞相比,用藻酸酶预处理144MR细胞可显著增强其对妥布霉素的早期摄取(P = 0.08)。在菌株144NM(而非菌株114MR)中,存在一种显著的抗生素后白细胞杀伤增强效应,表现为这些细胞短暂暴露于超最小抑菌浓度的阿米卡星后,非调理吞噬杀伤作用增强;用藻酸酶预处理菌株144MR可使这些细胞对阿米卡星诱导的抗生素后白细胞杀伤增强更敏感。同样,PMN介导的对黏液样菌株144MR的直接非调理吞噬杀伤作用显著低于对菌株144NM的观察结果(P小于0.05);用藻酸酶预处理144MR细胞可使该菌株在对非调理吞噬杀伤的敏感性上与菌株144NM相当。此外,外源性海藻酸钠或提取的144MR菌株的MEP会干扰PMN对144NM菌株的有效非调理吞噬杀伤作用。研究还表明,黏液样菌株144MR的吞噬作用明显低于其非黏液样配对菌株(P小于0.00001),用藻酸酶预处理黏液样细胞可逆转这种效应。这些数据证实,铜绿假单胞菌的MEP在体外功能上会降低氨基糖苷类药物的摄取和早期杀菌作用,并干扰有效的PMN介导的非调理吞噬作用及对黏液样菌株的杀伤。

相似文献

3
Alginase treatment of mucoid Pseudomonas aeruginosa enhances phagocytosis by human monocyte-derived macrophages.
Infect Immun. 1988 Nov;56(11):2788-93. doi: 10.1128/iai.56.11.2788-2793.1988.
5
Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa.
Clin Immunol Immunopathol. 1984 Aug;32(2):151-65. doi: 10.1016/0090-1229(84)90117-x.
6
Oxygen-dependent up-regulation of mucoid exopolysaccharide (alginate) production in Pseudomonas aeruginosa.
Infect Immun. 1990 May;58(5):1344-9. doi: 10.1128/iai.58.5.1344-1349.1990.
8
Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages.
Pediatr Res. 1987 Oct;22(4):429-31. doi: 10.1203/00006450-198710000-00013.
9
Opsonin-independent phagocytosis of Pseudomonas aeruginosa.
Antibiot Chemother (1971). 1985;36:88-94. doi: 10.1159/000410474.

引用本文的文献

2
Preparation and characterization of Meta-bromo-thiolactone calcium alginate nanoparticles.
Saudi Pharm J. 2022 Jul;30(7):946-953. doi: 10.1016/j.jsps.2022.05.008. Epub 2022 May 23.
3
The Specific Capsule Depolymerase of Phage PMK34 Sensitizes to Serum Killing.
Antibiotics (Basel). 2022 May 17;11(5):677. doi: 10.3390/antibiotics11050677.
4
The role of RNA regulators, quorum sensing and c-di-GMP in bacterial biofilm formation.
FEBS Open Bio. 2023 Jun;13(6):975-991. doi: 10.1002/2211-5463.13389. Epub 2022 Mar 13.
5
Effect of collagen and EPS components on the viscoelasticity of biofilms.
Soft Matter. 2021 Jun 30;17(25):6225-6237. doi: 10.1039/d1sm00463h.
6
Biofilm inhibitory effect of alginate lyases on mucoid from a cystic fibrosis patient.
Biochem Biophys Rep. 2021 May 26;26:101028. doi: 10.1016/j.bbrep.2021.101028. eCollection 2021 Jul.
7
The role of topical probiotics on wound healing: A review of animal and human studies.
Int Wound J. 2020 Dec;17(6):1687-1694. doi: 10.1111/iwj.13451. Epub 2020 Aug 31.
8
Targeting Biofilms Therapy: Current Research Strategies and Development Hurdles.
Microorganisms. 2020 Aug 11;8(8):1222. doi: 10.3390/microorganisms8081222.
9
Characterization of different alginate lyases for dissolving Pseudomonas aeruginosa biofilms.
Sci Rep. 2020 Jun 10;10(1):9390. doi: 10.1038/s41598-020-66293-2.
10
Pseudomonas aeruginosa Alginate Benefits Staphylococcus aureus?
J Bacteriol. 2020 Mar 26;202(8). doi: 10.1128/JB.00040-20.

本文引用的文献

3
Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.
Infect Immun. 1980 May;28(2):546-56. doi: 10.1128/iai.28.2.546-556.1980.
4
Isolation and characterization of an alginase from mucoid strains of Pseudomonas aeruginosa.
J Bacteriol. 1984 Sep;159(3):958-64. doi: 10.1128/jb.159.3.958-964.1984.
5
Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.
Infect Immun. 1984 Sep;45(3):748-55. doi: 10.1128/iai.45.3.748-755.1984.
6
Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.
Infect Immun. 1984 Mar;43(3):1006-11. doi: 10.1128/iai.43.3.1006-1011.1984.
7
Antibiotic penetration through bacterial capsules and exopolysaccharides.
J Antimicrob Chemother. 1982 Nov;10(5):368-72. doi: 10.1093/jac/10.5.368.
10
Mucoid Pseudomonas aeruginosa in patients with chronic illnesses.
Lancet. 1971 Jan 30;1(7692):236-7. doi: 10.1016/s0140-6736(71)90973-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验